Innovex holders sell 5M shares in offering
Innovex International, Inc. insiders affiliated with Amberjack Capital Partners and Innovex Co-Invest reported net sales of 5,000,000 shares of common stock on 2026-08-10.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Innovex International, Inc. insiders affiliated with Amberjack Capital Partners and Innovex Co-Invest reported net sales of 5,000,000 shares of common stock on 2026-08-10. The shares were sold indirectly by several investment funds in an underwritten secondary offering at $28.71 per share to Barclays Capital Inc., pursuant to a Rule 10b5-1 trading plan. After these sales, Amberjack Capital Fund II, L.P. reported holding 13,164,573 shares, with other affiliated funds retaining smaller positions, and Jason Turowsky disclaimed beneficial ownership beyond his pecuniary interests.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 5,000,000 shares
Net Sell
6 txns
Insider
Amberjack Capital Partners, L.P., Amberjack Capital Associates II, LLC, Amberjack Capital Fund II, L.P., Amberjack Capital GP II, L.P., Innovex Co-Invest Associates, LLC, Innovex Co-Invest Fund II GP, L.P., Innovex Co-Invest Fund II, L.P., Turowsky Jason, Amberjack Management, LLC
Role
Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner
Sold
5,000,000 shs ($143.55M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F7, F8, F9, F10 | 3,706,801 | $28.71 | $106.42M |
| Sale | Common Stock F2, F7, F8, F9, F10 | 865,508 | $28.71 | $24.85M |
| Sale | Common Stock F3, F7, F8, F9, F10 | 205,126 | $28.71 | $5.89M |
| Sale | Common Stock F4, F7, F8, F9, F10 | 176,944 | $28.71 | $5.08M |
| Sale | Common Stock F5, F7, F8, F9, F10 | 88 | $28.71 | $3K |
| Sale | Common Stock F6, F7, F8, F9, F10 | 45,533 | $28.71 | $1.31M |
Holdings After Transaction:
Common Stock — 13,164,573 shares (Indirect, By Amberjack Capital Fund II, L.P.);
Common Stock — 3,073,822 shares (Indirect, By Innovex Co-Invest Fund II, L.P.);
Common Stock — 728,498 shares (Indirect, By Innovex Co-Invest Fund, L.P.);
Common Stock — 628,411 shares (Indirect, By Intervale Capital Fund II, L.P.);
Common Stock — 311 shares (Indirect, By Intervale Capital Fund II-A, L.P.);
Common Stock — 161,707 shares (Indirect, By Intervale Capital Fund III, L.P.)
Footnotes (10)
- F1. Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to Barclays Capital Inc. (the "Underwriter") of $28.71 per share.
- F2. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
- F3. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
- F4. Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
- F5. Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
- F6. Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
- F7. The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.
- F8. (Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".
- F9. By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.
- F10. (Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.
Key Figures
Total shares sold: 5,000,000 shares
Sale price per share: $28.71
Amberjack Capital Fund II post-sale holdings: 13,164,573 shares
+5 more
8 metrics
Total shares sold
5,000,000 shares
Aggregate common stock sold by affiliated funds on 2026-08-10
Sale price per share
$28.71
Price to Barclays Capital Inc. as underwriter in the Offering
Amberjack Capital Fund II post-sale holdings
13,164,573 shares
Indirect holdings after its reported sale of common stock
Innovex Co-Invest Fund II post-sale holdings
3,073,822 shares
Indirect holdings after its reported sale of common stock
Innovex Co-Invest Fund post-sale holdings
728,498 shares
Indirect holdings after its reported sale of common stock
Intervale Capital Fund II post-sale holdings
628,411 shares
Indirect holdings after its reported sale of common stock
Intervale Capital Fund II-A post-sale holdings
311 shares
Indirect holdings after its reported sale of common stock
Intervale Capital Fund III post-sale holdings
161,707 shares
Indirect holdings after its reported sale of common stock
Key Terms
underwritten secondary offering, beneficial owner, voting and dispositive power, pecuniary interests
4 terms
underwritten secondary offering financial
"shares of common stock ... were sold in an underwritten secondary offering (the "Offering")"
An underwritten secondary offering is when existing shareholders sell a block of already-issued shares and an investment bank agrees to buy and resell them to the public, guaranteeing the sale will go through. Think of it as a store owner pre-selling a large shipment to a wholesaler who then sells it to customers; for investors, it can increase the number of shares available, affect short-term price pressure, and signal that insiders are taking profits or diversifying holdings.
beneficial owner financial
"therefore may be deemed to be the beneficial owner of such shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
voting and dispositive power financial
"control all voting and dispositive power over the reported shares held"
pecuniary interests financial
"Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider stock sales did Innovex International (INVX) report on August 10, 2026?
Innovex International (INVX) reported that affiliated funds sold 5,000,000 shares of common stock on 2026-08-10. The shares were sold indirectly by multiple Amberjack and Innovex Co-Invest funds in an underwritten secondary offering at $28.71 per share to Barclays Capital Inc.
Was the Innovex International (INVX) insider selling done under a Rule 10b5-1 trading plan?
Yes. The filing indicates the transactions were effected under a Rule 10b5-1 trading plan. This means the sales followed a pre-established trading arrangement, which can reduce the informational significance of the timing of the transactions for outside investors.
AI-generated analysis. How Rhea-AI works. Not financial advice.
